comorbidity

shutterstock_135966185

Introduction

Comorbidity, or the co-occurrence of two distinct medical conditions, is a common phrase in both physical and mental health. Whilst the term was originally conceived to describe medical phenomena, the term was adopted by psychiatry in the description of more than one clinical presentation occurring simultaneously. However, its use in psychiatry is not without controversy. 

What we know already

Large-scale prevalence data can seemingly tell us much about the high rate of comorbidity in mental health. Data from US National Comorbidity Survey, for example, suggested that, of those reporting mental health difficulties (across a 12-month prevalence), only 55% carried a single psychiatric diagnosis.

One important area of recent research concerns the rates of comorbidity of physical and mental health difficulties, particularly in the area of chronic health conditions. Mental Elf blogs have reported that people with schizophrenia are significantly more likely to die from heart disease and cancer; while the National Schizophrenia Audit calls for improved monitoring of physical health in people with schizophrenia. We know that depression and anxiety are more common when a person has a chronic health problem, and this comorbidity leads to poorer clinical and quality of life outcomes. This has led to an increase in interventions targeting the psychological consequences of chronic ill health.

Areas of uncertainty

The controversy in psychiatric comorbidity is the issues of mutual exclusivity. We are not able to conclude as to whether ‘comorbid’ psychiatric diagnoses are separate clinical entities, or multiple features of the same underlying cause. This has led to much criticism of the term ‘psychiatric comorbidity’.

Furthermore, certain diagnostic labels, such as personality disorders, attract particular scrutiny, due to their high levels of comorbidity with other mental health diagnoses. Similarly, people often meet the criteria for more than one personality disorder. This again creates uncertainty as to the precise nature of the condition, or conditions, being diagnosed.

What’s in the pipeline?

The recent publication of the Diagnostic and Statistic Manual (DSM)-5 seemingly retains the notion that multiple distinct clinical diagnoses exist, thus maintaining the argument for psychiatric comorbidity. Alternative conceptualisations have been suggested, along dimensional models, such as ‘anxious-misery’, ‘externalising’ and ‘fear-based’ dimensions. However, these were not adopted in the DSM-5.

As our understanding of mental health conditions continues to improve, so too hopefully will our understanding of comorbidity, and its relevance to psychological and psychiatric phenomena.

References

First, M. B. (2005). Mutually exclusive versus co-occurring diagnostic categories: the challenge of diagnostic comorbidity. Psychopathology, 38, 206-210. [Abstract]

Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of general psychiatry, 62, 617-627. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK. [Full text]

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Sep 2015
Review due: Sep 2016

Our comorbidity Blogs

People with severe mental illness die younger and things are getting worse

headstone-309454_1280

Judith Harrison publishes her debut blog on a recent cohort study in the British Journal of Psychiatry, which shows that the “mortality gap” is increasing for people with bipolar disorder and schizophrenia.

[read the full story...]

Quality of general hospital care through the liaison psychiatry lens?

4141273204_eef723ae17_b

Kirsten Lawson explores a recent study of liaison psychiatry professionals’ views of general hospital care for patients with mental illness.

[read the full story...]

CBT may help reduce anxiety and depression in people with diabetes, but standardised approach needed

200164357-001

Ben Perry explores the findings of a recent systematic review looking at the effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes.

[read the full story...]

Life expectancy in schizophrenia and years of potential life lost

tristan-colangelo-39719

Joanne Wallace summarises a recent systematic review and meta-analysis that reinforces the urgent call for better interventions to address the causes of premature death in schizophrenia.

[read the full story...]

Early life deprivation, neurodevelopment, mental health and resilience: ERA study

codruta

André Tomlin summarises the latest instalment of the ERA (English and Romanian Adoptees) study, which explores the neurodevelopmental and mental health trajectories of Romanian orphans who experienced severe levels of early life deprivation.

Today’s blog features a podcast interview with lead author of the ERA study: Professor Edmund Sonuga-Barke.

[read the full story...]

In search of the sweet spot: the links between dysglycaemia and first episode psychosis

lump-sugar-549096_1280

Ben Perry publishes his debut blog on a recent systematic review of impaired glucose homeostasis in first-episode schizophrenia.

[read the full story...]

New NICE guidance on dual diagnosis: sterile or infectious?

12926724243_ba70969598_k

Ian Hamilton and Mark Holland appraise new NICE guidance on dual diagnosis. Their blog highlights the ongoing inequity in service provision for people with serious mental illness and comorbid substance misuse.

[read the full story...]

Substance misuse and addiction in people with intellectual and developmental disabilities

drinking-997189_640

Andrew Jones summarises a recent Canadian cohort study, which explores the extent of substance misuse and addictive disorders among adults with intellectual and developmental disabilities.

[read the full story...]

Antipsychotic efficacy measured by real-world observational study

telescope-1082091_640

Tracey Roberts examines whether a retrospective observational study accurately investigates the effectiveness of second and first generation antipsychotics.

[read the full story...]

Chronic pain and depression: genetic and environmental risks

5725464417_183424f30a_b

Marcus Munafo explores a recent study that uses genetic data and family environmental information to quantify the risk of chronic pain and the contribution of risk variants for major depressive disorder.

[read the full story...]